Related Experiment Video
Updated: May 5, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
Stabilizing nitric oxide: MnFe2O4@Cap-SNO nanoparticles and chitosan hydrogels for controlled therapeutic delivery
Soodabeh Gharibeh1, Melika JaberebnAnsari2, Elham Askarizadeh2
1Department of Science, Fi.C., Islamic Azad University, Firoozkooh, Iran.
None:
Nitric oxide (NO) is a vital bioactive molecule, but its rapid degradation limits therapeutic applications. To enhance stability and controlled release, two novel systems were synthesized: MnFe2O4@Cap-SNO nanoparticles and Cs@Cap-SNO hydrogel. MnFe2O4@Cap-SNO, incorporating captopril (Cap) as an NO donor, demonstrated prolonged NO release for up to 16h upon light exposure, following zero-order kinetics, ensuring sustained delivery. Cs@Cap-SNO, a chitosan-based hydrogel integrating nitrosated captopril (Cap-SNO), exhibited faster NO release governed by Korsmeyer-Peppas kinetics. UV-Vis spectrophotometry confirmed successful nitrosation with distinct absorption bands at 335nm and 545nm. MnFe2O4@Cap-SNO displayed superior stability, outperforming Cs@Cap-SNO and free Cap-SNO in NO preservation. These findings suggest MnFe2O4@Cap-SNO as an effective NO-stabilizing carrier for biomedical applications, particularly intargeted drug delivery. Future studies will focus on in vitro and in vivo validation to assess therapeutic efficacy.
Related Concept Videos
Nitric Oxide Signaling Pathway
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Site-Targeted Drug Delivery Systems: Polymeric Carriers

